Aquestive Therapeutics, Inc. AQST Asset Retirement Obligation
Asset Retirement Obligation at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetRetirementObligation.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s asset retirement obligation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s asset retirement obligation?
- Aquestive Therapeutics, Inc. (AQST) reported asset retirement obligation of $2.07M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s asset retirement obligation changed year-over-year?
- Aquestive Therapeutics, Inc.'s asset retirement obligation increased by 1.3% year-over-year, from $2.05M to $2.07M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s asset retirement obligation?
- Over 3 years (2022 to 2025), Aquestive Therapeutics, Inc.'s asset retirement obligation has grown at a 1.3% compound annual growth rate (CAGR), from $1.99M to $2.07M.